A drug called buprenorphine may be the best tool doctors have to fight the fentanyl crisis. Why hasn’t it been more widely ...

Less than 7% of individuals with mental health or substance use disorders receive effective treatment worldwide, according to a cross-sectional analysis published in JAMA Psychiatry.The findings ...

The FDA has approved an oral, small molecule MEK inhibitor for adult and pediatric patients 2 years of age and older with ...

Started by a patient, HealthTree lets blood cancer patients look for clinical trials and treatment options, share their data with researchers.

To manage the daily pain, frequent brain fog, and sporadic days of full-body exhaustion, my primary care doctor suggested a ...

The first four treatments in a platform trial for amyotrophic lateral sclerosis (ALS) failed to reach key endpoints in phase ...

Cleveland Clinic researchers are using artificial intelligence to identify existing FDA-approved drugs that may be repurposed to treat other complex diseases. The effort is led by Feixiong Cheng, PhD, ...

Clinical outcomes for ulcerative colitis patients with a prior anti-TNF therapy failure appeared similar with ustekinumab ...

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall recurrence and treatment failure. Patients with HRR-deficient metastatic ...

Other sufferers were not so lucky. Now, the medical establishment is finally coming to grips with the treatment of ME (myalgic encephalomyelitis or chronic fatigue syndrome), an illness that robs ...

Pfizer (PFE) announced that the U.S. FDA has approved the supplemental Biologics License Application for ADCETRIS in combination with lenalidomide ...

A home is never fully finished - at least not for those who are passionate about gardening and interiors. Whether you're looking to lighten your homes dark corners or brighten up your flowerbeds ...